« Previous
Next »
Subjects
- Cost-Benefit Analysis[remove]21
- Humans21
- United States21
- Treatment Outcome13
- Randomized Controlled Trials as Topic7
- Clinical Trials as Topic4
- Antibodies, Monoclonal -- adverse effects3
- Antibodies, Monoclonal -- therapeutic use3
- Certolizumab Pegol -- therapeutic use3
- Comparative Effectiveness Research3
- Immunologic Factors -- adverse effects3
- Immunologic Factors -- therapeutic use3
- United States. Department of Health and Human Services.3
- United States. Food and Drug Administration.3
- Abatacept -- therapeutic use2
- Adalimumab -- therapeutic use2
- Analgesics, Opioid -- therapeutic use2
- Antirheumatic Agents -- adverse effects2
- Antirheumatic Agents -- therapeutic use2
- Arthritis, Rheumatoid -- drug therapy2